J Mark FitzGerald Selected Research

J Mark FitzGerald Research Topics

Disease

115	Asthma (Bronchial Asthma) 11/2023 - 11/2003
33	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 01/2005
13	Inflammation (Inflammations) 01/2023 - 05/2014
4	Symptom Flare Up 01/2022 - 01/2022
4	Infections 01/2013 - 09/2008
3	Respiratory Sounds (Crackle) 09/2015 - 11/2009
3	Dyspnea (Shortness of Breath) 01/2013 - 10/2005
3	Tuberculosis (Tuberculoses) 09/2011 - 09/2005
2	Allergic Rhinitis 11/2023 - 11/2020
2	Nasal Polyps (Nasal Polyp) 11/2023 - 01/2021
2	Fibrosis (Cirrhosis) 12/2020 - 02/2012
2	Airway Remodeling 12/2020 - 01/2018
2	Latent Tuberculosis 01/2020 - 01/2013
2	Eosinophilia 01/2018 - 10/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 09/2009
1	Rhinosinusitis 11/2023
1	Atopic Dermatitis (Atopic Eczema) 11/2023
1	Dermatitis 11/2023
1	Obesity 08/2023
1	Dyslipidemias (Dyslipidemia) 08/2023
1	Bronchiectasis 08/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Bronchitis 01/2023
1	Eczema 01/2021
1	Perennial Allergic Rhinitis 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Pneumonia (Pneumonitis) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Pulmonary Edema 01/2018
1	Adenoma (Adenomas) 01/2017
1	Pancytopenia 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2016
1	Nasopharyngitis 10/2016

Drug/Important Bio-Agent (IBA)

57	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 11/2003
19	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 11/2003
16	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2016
15	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 01/2005
15	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 11/2003
11	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 03/2017
11	benralizumabIBA 01/2022 - 10/2016
8	AllergensIBA 01/2023 - 11/2012
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 05/2014
8	Terbutaline (Brethaire)FDA LinkGeneric 12/2021 - 01/2008
8	Monoclonal AntibodiesIBA 12/2020 - 10/2016
6	mepolizumabIBA 05/2023 - 09/2014
6	SteroidsIBA 01/2023 - 04/2005
6	dupilumabIBA 01/2023 - 01/2018
6	Immunoglobulin E (IgE)IBA 11/2022 - 10/2016
6	Tiotropium Bromide (Spiriva)FDA Link 11/2020 - 01/2005
5	Methacholine Chloride (Methacholine)FDA Link 01/2023 - 01/2018
5	Muscarinic AntagonistsIBA 01/2022 - 11/2020
5	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2021 - 04/2012
5	Formoterol Fumarate Drug Combination Budesonide FDA Link 12/2021 - 11/2003
5	GlucocorticoidsIBA 10/2021 - 09/2014
5	Interleukin-13IBA 12/2020 - 01/2017
4	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2017
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2022
4	Omalizumab (Xolair)FDA Link 01/2022 - 11/2015
3	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2019 - 10/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 10/2005
3	Salmeterol Xinafoate (Serevent)FDA Link 09/2014 - 01/2005
2	ORALIT (ORS)IBA 08/2023 - 03/2011
2	anti-IgE antibodiesIBA 01/2023 - 01/2021
2	reslizumabIBA 01/2022 - 12/2019
2	Interleukin-4 (Interleukin 4)IBA 11/2020 - 01/2017
2	InterleukinsIBA 11/2020 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 01/2013
2	Prednisone (Sone)FDA LinkGeneric 08/2019 - 02/2013
2	GoldIBA 01/2019 - 11/2016
2	C-Reactive ProteinIBA 01/2018 - 01/2017
2	CytokinesIBA 01/2017 - 05/2014
2	Fluticasone (Cutivate)FDA LinkGeneric 09/2014 - 04/2005
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 09/2014 - 01/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 06/2006
2	Oxygen (Dioxygen)IBA 07/2009 - 01/2007
1	Immunoglobulin FragmentsIBA 01/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	NemiralisibIBA 01/2021
1	lebrikizumabIBA 12/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019
1	antiarrhythmic peptide (AAP)IBA 10/2018
1	PlacebosIBA 01/2018
1	tralokinumabIBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Natriuretic PeptidesIBA 10/2017
1	PeriostinIBA 09/2017
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2017

Therapy/Procedure

55	Therapeutics 05/2023 - 11/2003
11	Nebulizers and Vaporizers (Inhaler) 11/2019 - 11/2003
9	Biological Therapy 02/2024 - 12/2021
3	Drug Therapy (Chemotherapy) 04/2021 - 10/2014
2	Precision Medicine 05/2023 - 01/2019
2	Ambulatory Care (Outpatient Care) 02/2016 - 09/2011
2	Bronchial Thermoplasty 01/2016 - 09/2015
1	Inappropriate Prescribing 03/2017